|
|
.
NPI Detail
NPI: 1376544320
Type: Organization
Taxonomy Code: 282N00000X
Hospital-General
Hospitals/General Acute Care Hospital
200 XXXXXXX XX
IOWA CITY, IA 52242
Mailing and Business location phone:
(XXX) XXX-XXXX
|
Click here for new NPI search.
|
2021 OPPS Part A Medicare Services Submitted NPI-1376544320*
OPPS Payment Method "A" - Services not paid under OPPS; uses a different fee schedule (e.g., ambulance, PT, mammography)
Top Level I HCPC Procedures
| Procedure | Description | Number Submitted | Medicare Payment |
| 36415
|
ROUTINE VENIPUNCTURE
|
XXXXX
|
$XXXXX.XX
|
| 85025
|
COMPLETE CBC W/AUTO DIFF WBC
|
XXXXX
|
$XXXXX.XX
|
Top Drugs Administered Other than Oral Method
| Procedure | Description | Number Submitted | Medicare Payment |
| J7207
|
Factor viii pegylated recomb
|
XXXXXXX
|
$XXXXXXX.XX
|
| J7205
|
Factor viii fc fusion recomb
|
XXXXXXX
|
$XXXXXXX.XX
|
| J7204
|
Inj recombin esperoct per iu
|
XXXXXXX
|
$XXXXXXX.XX
|
| J7192
|
Factor viii recombinant nos
|
XXXXXX
|
$XXXXXX.XX
|
| J9271
|
Inj pembrolizumab
|
XXXXXX
|
$XXXXXXX.XX
|
| J1439
|
Inj ferric carboxymaltos 1mg
|
XXXXXX
|
$XXXXXX.XX
|
| J2795
|
Ropivacaine hcl injection
|
XXXXXX
|
-
|
| J8540
|
Oral dexamethasone
|
XXXXXX
|
-
|
| J2704
|
Inj, propofol, 10 mg
|
XXXXXX
|
-
|
| J3380
|
Injection, vedolizumab
|
XXXXXX
|
$XXXXXXX.XX
|
| J9299
|
Injection, nivolumab
|
XXXXXX
|
$XXXXXXX.XX
|
| J9267
|
Paclitaxel injection
|
XXXXXX
|
-
|
| J0585
|
Injection,onabotulinumtoxina
|
XXXXXX
|
$XXXXXX.XX
|
| J9264
|
Paclitaxel protein bound
|
XXXXXX
|
$XXXXXX.XX
|
| J9263
|
Oxaliplatin
|
XXXXX
|
-
|
| J9176
|
Injection, elotuzumab, 1mg
|
XXXXX
|
$XXXXXX.XX
|
| J1561
|
Gamunex-c/gammaked
|
XXXXX
|
$XXXXXXX.XX
|
| J0881
|
Darbepoetin alfa, non-esrd
|
XXXXX
|
$XXXXXX.XX
|
| J7189
|
Factor viia recomb novoseven
|
XXXXX
|
$XXXXXX.XX
|
| J9171
|
Docetaxel injection
|
XXXXX
|
-
|
| J0897
|
Denosumab injection
|
XXXXX
|
$XXXXXX.XX
|
| J2426
|
Inj, invega sustenna, 1 mg
|
XXXXX
|
$XXXXXX.XX
|
| J9144
|
Daratumumab, hyaluronidase
|
XXXXX
|
$XXXXXXX.XX
|
| J7170
|
Inj., emicizumab-kxwh 0.5 mg
|
XXXXX
|
$XXXXXX.XX
|
| J7185
|
Xyntha inj
|
XXXXX
|
$XXXXX.XX
|
| J1100
|
Dexamethasone sodium phos
|
XXXXX
|
-
|
| J7187
|
Humate-p, inj
|
XXXXX
|
$XXXXX.XX
|
| J2350
|
Injection, ocrelizumab, 1 mg
|
XXXXX
|
$XXXXXXX.XX
|
| J7195
|
Factor ix recombinant nos
|
XXXXX
|
$XXXXX.XX
|
Top HCPC Level II Procedures / Professional Services
| Procedure | Description | Number Submitted | Medicare Payment |
| G0463
|
Hospital outpt clinic visit
|
XXXXXX
|
$XXXXXXX.XX
|
| G0378
|
Hospital observation per hr
|
XXXXX
|
-
|
* Medicare Part A utilization data is derived from the 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
|
